Mylan Laboratories Profile
Key Indicators
- Authorised Capital ₹ 125.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 48.70 Cr
as on 23-10-2024
- Company Age 39 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 5,501.38 Cr
as on 23-10-2024
- Revenue -8.72%
(FY 2023)
- Profit -25.28%
(FY 2023)
- Ebitda -5.28%
(FY 2023)
- Net Worth 4.07%
(FY 2023)
- Total Assets 0.52%
(FY 2023)
About Mylan Laboratories
The Corporate was formerly known as Herren Drugs & Pharmaceuticals Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 125.00 Cr and a paid-up capital of Rs 48.70 Cr.
The company has closed loans amounting to ₹5,501.38 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Mylan Laboratories Limited India are Sarada Bhagawati as CFO and Nagaraj Bodige as Company Secretary. Rajiv Malik, Sarada Bhagawati, Akshay Nanda, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24231TG1984PLC005146
- Company No.
005146
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
29 Nov 1984
- Date of AGM
31 Jul 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Mylan Laboratories Limited offer?
Mylan Laboratories Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, HIV Drugs, Pain Relief Drugs & Pharmaceuticals, Antipyretic Medication, Tenofovir Tablet, Anti Infective Agent, Pain Relief Spray, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Antibiotic Injection.
Who are the key members and board of directors at Mylan Laboratories?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sarada Bhagawati  | CFO | 01-Nov-2014 | Current |
| Nagaraj Bodige | Company Secretary | 25-Jul-2011 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajiv Malik | Director | 28-Jul-2005 | Current |
| Sarada Bhagawati | Whole-Time Director and Cfo | 01-Nov-2014 | Current |
| Akshay Nanda | Director | 11-Mar-2024 | Current |
| Arvind Kanda | Whole-Time Director | 02-Apr-2024 | Current |
| Ramya Suresh | Director | 14-May-2024 | Current |
Financial Performance and Corporate Structure Insights of Mylan Laboratories.
Mylan Laboratories Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.72% decrease. The company also saw a substantial fall in profitability, with a 25.28% decrease in profit. The company's net worth moved up by a moderate rise of 4.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mylan Laboratories?
In 2023, Mylan Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Icici Bank Limited Creation Date: 11 Jun 2013 | ₹170.00 Cr | Satisfied |
Yes Bank Limited Creation Date: 27 Nov 2012 | ₹40.00 Cr | Satisfied |
Export - Import Bank Of India Creation Date: 08 Oct 2012 | ₹150.00 Cr | Satisfied |
How Many Employees Work at Mylan Laboratories?
Mylan Laboratories has a workforce of 11193 employees as of Mar 25, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mylan Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mylan Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
